Learn why primary biliary cholangitis (PBC) causes intense itching, and explore treatment options, management tips, and ...

The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The ...

According to the results of a new international study, there may be a role for insulin-like growth factor-binding protein 4 (IGFBP4) in facilitating the interaction between macrophages and injured ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD), following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE ...

A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions, uncertainties and a need to redefine what life looks like with a chronic ...

The European Medicines Agency (EMA) has recommended that a conditional marketing authorization should be granted for Iqirvo (elafibranor; Ipsen Pharma) for treating primary biliary cholangitis (PBC).

Please provide your email address to receive an email when new articles are posted on . Gilead’s Livdelzi, a selective peroxisome proliferator-activated receptor delta agonist, has received ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi ® (seladelpar) ...

Intercept Pharmaceuticals has voluntarily withdrawn Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) from the US market. The decision follows a request from the FDA.

Patients with primary biliary cholangitis (PBC) can use linerixibat to address cholestatic pruritus, which up to 89% of ...